| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -98.73% | - | - | 92.63K | ||
| +0.35% | -4.87% | +49.87% | +157.34% | 1,031B | ||
| -2.69% | -6.22% | +59.19% | +54.51% | 595B | ||
| -0.27% | -3.41% | +30.97% | +79.48% | 431B | ||
| -0.44% | -1.94% | +28.42% | +22.67% | 326B | ||
| -0.20% | -1.96% | +28.11% | +43.50% | 277B | ||
| -0.94% | -6.66% | +19.43% | +22.20% | 263B | ||
| +0.92% | +4.39% | -22.92% | -37.65% | 224B | ||
| +0.86% | -2.63% | +22.50% | +57.55% | 193B | ||
| +1.28% | -3.03% | +20.76% | +70.62% | 164B | ||
| Average | -0.12% | -3.79% | +26.26% | +52.25% | 389.37B | |
| Weighted average by Cap. | -0.35% | -4.31% | +35.61% | +76.62% |
Employees
4
Sector
Pharmaceuticals
















